This FDA-Approved Drug Slows Down Alzheimer's. We Finally Know Why.This FDA-Approved Drug Slows Down Alzheimer's. We Finally Know Why. - ScienceAlert
sciencealert.comSubmitted by sciencealert6623 in health
Lecanemab received FDA approval in January after a phase 3 trial showed it slows cognitive decline in early-stage Alzheimer's patients.